07/10/2025 11:15 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form EFFECT | |
07/10/2025 4:05 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 424B3 | |
07/09/2025 8:00 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/30/2025 3:05 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2025 3:01 PM | MetaVia Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) MetaVia Inc. (Issuer) Woodworth Marshall H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2025 4:06 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/27/2025 3:16 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form PRE 14A | |
05/21/2025 7:30 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2025 3:15 PM | DONG-A ST CO., LTD (Filed by) MetaVia Inc. (Subject) NeuroBo Pharmaceuticals (Subject) MetaVia Inc. (Subject)
| Form SCHEDULE 13D/A | |
05/20/2025 3:16 PM | DONG-A ST CO., LTD (Reporting) MetaVia Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) MetaVia Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2025 8:03 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for NRBO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
05/07/2025 6:00 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/22/2025 7:33 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/15/2025 6:01 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2025 6:44 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 424B3 | |
04/03/2025 11:15 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form EFFECT | |
03/27/2025 4:05 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form POS AM | |
03/27/2025 4:07 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2025 4:15 PM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/20/2025 6:31 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 7:30 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 7:30 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/02/2024 4:31 PM | Kim Hyung Heon (Reporting) MetaVia Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) MetaVia Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2024 8:10 AM | MetaVia Inc. (Filer) NeuroBo Pharmaceuticals (Filer) MetaVia Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/18/2024 7:35 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2024 6:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 7:07 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 3:20 PM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2024 3:10 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 7:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form PRE 14A | |
07/30/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2024 11:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form EFFECT | |
07/24/2024 4:11 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form 424B3 | |
07/18/2024 7:21 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer) NeuroBo Pharmaceuticals, Inc. (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |